Abstract
Based on the Se-N bond modify strategy emerging from ebselen, a facile, solvent-free cascade selenenylation-acylation reaction for synthesis of novel 2-((2-oxopropyl)selanyl) benzamide organoselenium compounds was developed, by using 2-chloroselenobenzoyl chloride as biselectrophile reagent, where acetone as primary nucleophile for the selenenylation reaction, and amine as secondary nucleophile for the acylation. In vitro cytotoxicity was evaluated by using CCK8 assay, and some of the newly synthesized compounds exhibited equally or superior activities to cisplatin against five cancer cell lines, including A549, EC109, HCT116, HepG2, and MCF-7.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
